27011 Dupilumab for treatment of atopic dermatitis in patients living with HIV
Journal of the American Academy of Dermatology(2021)
摘要
Background: HIV has long been known to be associated with a wide spectrum of cutaneous manifestations that have continued to evolve in the era of highly active antiretroviral therapy (HAART). Atopic dermatitis has an incidence as high as 37.5% in patients living with HIV, often refractory to multiple treatment modalities. We describe a series of 4 patients living with HIV treated with dupilumab for atopic dermatitis and other pruritic disorders, achieving considerable clinical improvement while maintaining control of HIV.
更多查看译文
关键词
atopic dermatitis,dupilumab,hiv,treatment
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要